Breast Cancer (Therapy)

Cost-Effectiveness of Experimental Treatments Compared

Published in Cancer Weekly, November 20th, 1995

Federal antitrust officials gave their approval to major cancer centers to conduct a study comparing the cost and effectiveness of experimental breast cancer treatments.

The aim is to help the centers gather information to persuade insurance companies to cover the cost of treatments still in clinical trials.

Assistant Attorney General Anne K. Bingaman told the Southwest Oncology Group in San Antonio, Texas, and its clinical practices committee that they will be able to share the information among member hospitals. The group includes several dozen major universities and hospitals that specialize in treating cancer patients.

The...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cancer Weekly

Source: Cancer Weekly (1995-11-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry